The U.S. Department of Justice says the David Geffen School of Medicine at the University of California, Los Angeles, illegally considered race when selecting applicants for admission. In a findings letter released by the DOJ’s Civil Rights Division, the agency states UCLA’s medical school violated Title VI of the Civil Rights Act of 1964 by granting and denying admission based on applicants’ race, including after the U.S. Supreme Court’s 2023 decision in Students for Fair Admissions v. Harvard, which barred race-conscious admissions decisions at colleges and universities.

Multiple outlets report that the DOJ’s review relied on internal materials and communications, which it says show the school continued to pursue “diversity goals” through admissions strategies after the Supreme Court ruling. The DOJ also alleges that admission outcomes correlated with race: in some years, Black and Hispanic admitted students averaged MCAT scores in the 66th to 72nd percentiles, while Asian and White admitted students averaged mid-to-high 80th percentiles.

UCLA denies wrongdoing, with the school stating its process is based on merit and a rigorous, comprehensive review, and that it is committed to complying with federal and state law. The reports describe the DOJ action as part of a broader increase in federal scrutiny of admissions practices, particularly those tied to DEI efforts.